Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 275

    1.

    MDM2 is a novel E3 ligase for HIV-1 Vif.

    Izumi T, Takaori-Kondo A, Shirakawa K, Higashitsuji H, Itoh K, Io K, Matsui M, Iwai K, Kondoh H, Sato T, Tomonaga M, Ikeda S, Akari H, Koyanagi Y, Fujita J, Uchiyama T.

    Retrovirology. 2009 Jan 7;6:1.

    PMID:
    19128510
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Regulation of Apobec3F and human immunodeficiency virus type 1 Vif by Vif-Cul5-ElonB/C E3 ubiquitin ligase.

    Liu B, Sarkis PT, Luo K, Yu Y, Yu XF.

    J Virol. 2005 Aug;79(15):9579-87.

    PMID:
    16014920
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    3.

    Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.

    He Z, Zhang W, Chen G, Xu R, Yu XF.

    J Mol Biol. 2008 Sep 12;381(4):1000-11. Epub 2008 Jun 28.

    PMID:
    18619467
    [PubMed - indexed for MEDLINE]
    4.

    The HIV-1 Vif PPLP motif is necessary for human APOBEC3G binding and degradation.

    Donahue JP, Vetter ML, Mukhtar NA, D'Aquila RT.

    Virology. 2008 Jul 20;377(1):49-53. Epub 2008 May 21.

    PMID:
    18499212
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    5.

    Distinct determinants in HIV-1 Vif and human APOBEC3 proteins are required for the suppression of diverse host anti-viral proteins.

    Zhang W, Chen G, Niewiadomska AM, Xu R, Yu XF.

    PLoS One. 2008;3(12):e3963. Epub 2008 Dec 17.

    PMID:
    19088851
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    6.

    HIV-1 Vif-mediated ubiquitination/degradation of APOBEC3G involves four critical lysine residues in its C-terminal domain.

    Iwatani Y, Chan DS, Liu L, Yoshii H, Shibata J, Yamamoto N, Levin JG, Gronenborn AM, Sugiura W.

    Proc Natl Acad Sci U S A. 2009 Nov 17;106(46):19539-44. Epub 2009 Nov 3.

    PMID:
    19887642
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    7.

    Characterization of a novel Cullin5 binding domain in HIV-1 Vif.

    Xiao Z, Xiong Y, Zhang W, Tan L, Ehrlich E, Guo D, Yu XF.

    J Mol Biol. 2007 Oct 26;373(3):541-50. Epub 2007 Jul 26.

    PMID:
    17869271
    [PubMed - indexed for MEDLINE]
    8.

    Regulation of APOBEC3 proteins by a novel YXXL motif in human immunodeficiency virus type 1 Vif and simian immunodeficiency virus SIVagm Vif.

    Pery E, Rajendran KS, Brazier AJ, Gabuzda D.

    J Virol. 2009 Mar;83(5):2374-81. Epub 2008 Dec 24.

    PMID:
    19109396
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    9.

    The SOCS-box of HIV-1 Vif interacts with ElonginBC by induced-folding to recruit its Cul5-containing ubiquitin ligase complex.

    Bergeron JR, Huthoff H, Veselkov DA, Beavil RL, Simpson PJ, Matthews SJ, Malim MH, Sanderson MR.

    PLoS Pathog. 2010 Jun 3;6(6):e1000925.

    PMID:
    20532212
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    10.

    Identification of 81LGxGxxIxW89 and 171EDRW174 domains from human immunodeficiency virus type 1 Vif that regulate APOBEC3G and APOBEC3F neutralizing activity.

    Dang Y, Davis RW, York IA, Zheng YH.

    J Virol. 2010 Jun;84(11):5741-50. Epub 2010 Mar 24.

    PMID:
    20335268
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    12.

    Distinct domains within APOBEC3G and APOBEC3F interact with separate regions of human immunodeficiency virus type 1 Vif.

    Russell RA, Smith J, Barr R, Bhattacharyya D, Pathak VK.

    J Virol. 2009 Feb;83(4):1992-2003. Epub 2008 Nov 26.

    PMID:
    19036809
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    14.

    Ubiquitination of APOBEC3G by an HIV-1 Vif-Cullin5-Elongin B-Elongin C complex is essential for Vif function.

    Kobayashi M, Takaori-Kondo A, Miyauchi Y, Iwai K, Uchiyama T.

    J Biol Chem. 2005 May 13;280(19):18573-8. Epub 2005 Mar 21.

    PMID:
    15781449
    [PubMed - indexed for MEDLINE]
    Free Article
    15.

    Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation.

    Mehle A, Goncalves J, Santa-Marta M, McPike M, Gabuzda D.

    Genes Dev. 2004 Dec 1;18(23):2861-6.

    PMID:
    15574592
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    16.

    Ubiquitin-fusion as a strategy to modulate protein half-life: A3G antiviral activity revisited.

    Cadima-Couto I, Freitas-Vieira A, Nowarski R, Britan-Rosich E, Kotler M, Goncalves J.

    Virology. 2009 Oct 25;393(2):286-94. Epub 2009 Aug 29.

    PMID:
    19717177
    [PubMed - indexed for MEDLINE]
    17.

    APOBEC3G and APOBEC3F require an endogenous cofactor to block HIV-1 replication.

    Han Y, Wang X, Dang Y, Zheng YH.

    PLoS Pathog. 2008 Jul 4;4(7):e1000095.

    PMID:
    18604271
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    18.

    Polyubiquitination of APOBEC3G is essential for its degradation by HIV-1 Vif.

    Shao Q, Wang Y, Hildreth JE, Liu B.

    J Virol. 2010 May;84(9):4840-4. Epub 2010 Feb 10.

    PMID:
    20147392
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    19.

    APOBEC3G is degraded by the proteasomal pathway in a Vif-dependent manner without being polyubiquitylated.

    Dang Y, Siew LM, Zheng YH.

    J Biol Chem. 2008 May 9;283(19):13124-31. Epub 2008 Mar 6.

    PMID:
    18326044
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    20.

    Adenovirus E4orf6 assembles with Cullin5-ElonginB-ElonginC E3 ubiquitin ligase through an HIV/SIV Vif-like BC-box to regulate p53.

    Luo K, Ehrlich E, Xiao Z, Zhang W, Ketner G, Yu XF.

    FASEB J. 2007 Jun;21(8):1742-50. Epub 2007 Mar 9.

    PMID:
    17351129
    [PubMed - indexed for MEDLINE]
    Free Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk